A multiplex qPCR kit for the detection of Chagas Disease (Kissing Bug)
Hepatitis B virus (HBV) and hepatitis C virus (HCV) are two common bloodborne pathogens with similar symptoms such as fatigue, jaundice, and liver inflammation. They are important targets in the human health sector as they can lead to chronic liver infections, cirrhosis, and liver cancer if left undetected. Early detection of HBV and HCV is crucial to prevent the spread of infection and to initiate timely treatment, especially in high-risk populations such as healthcare workers and individuals with a history of injection drug use.
YouSeq's qPCR kit to detect HBV and HCV allows for sensitive and specific detection of these viral pathogens, enabling early diagnosis and intervention. Rapid and accurate detection of HBV and HCV can lead to improved patient outcomes, reduced transmission rates, and lower healthcare costs associated with managing late-stage liver diseases. Detecting these targets early can also help in implementing preventive measures to control the spread of these infectious diseases within the community.
Available for delivery in United States
Price on enquiry
Order nowFor Research Use Only. Not intended for diagnostic use.
Contents
Technical specification
Product variants
Useful links
1. Development of conventional and real-time multiplex PCR-based assays for estimation of natural infection rates and Trypanosoma cruzi load in triatomine vectors. ; Moreira OC et al. ; 2017 Aug 29 ; https://pubmed.ncbi.nlm.nih.gov/28851417/
2. Genotypic Trypanosoma cruzi distribution and parasite load differ ecotypically and according to parasite genotypes in Triatoma brasiliensis from endemic and outbreak areas in Northeastern Brazil. ; Moreira OC et al. ; 2021 Oct ; https://pubmed.ncbi.nlm.nih.gov/34273309/
Pseudonyms
Chagas disease; kissing bug disease; American trypanosomiasis; Trypanosoma cruzi; Chagas fever; Romana's signRelated products
Still scrolling? We love adventurers
We work at the cutting edge of molecular biology, striving to disrupt our industry. We drive continuous product innovation and we aren’t afraid to take on new challenges.
More about usRelated learning resources